Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study

Abstract Cerebral venous sinus thrombosis (CVST) is a rare and devastating complication of inflammatory bowel disease (IBD). Early diagnosis and prompt treatment could improve prognosis. The aim of our study was to investigate the clinical data and predictive factors of inflammatory bowel disease in...

Full description

Bibliographic Details
Main Authors: Wang Shujun, Zhang Huijie, Bai Xia, Wang Hongjian
Format: Article
Language:English
Published: Nature Portfolio 2021-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-96541-y
_version_ 1818716932351721472
author Wang Shujun
Zhang Huijie
Bai Xia
Wang Hongjian
author_facet Wang Shujun
Zhang Huijie
Bai Xia
Wang Hongjian
author_sort Wang Shujun
collection DOAJ
description Abstract Cerebral venous sinus thrombosis (CVST) is a rare and devastating complication of inflammatory bowel disease (IBD). Early diagnosis and prompt treatment could improve prognosis. The aim of our study was to investigate the clinical data and predictive factors of inflammatory bowel disease in patients with a diagnosis of CVST. All IBD patient data were collected from July 2013 and September 2020. Clinical data, predictive factors and prognosis were compared between IBD patients with CVST and the IBD control group. The incidence of CVST in our study was 0.48%. The mean age of IBD patients with CVST was 34.9 years. The average duration of IBD was 4 years when cerebrovascular events occurred. The clinical presentation of CVST included headache (73.1%), vomiting (30.8%), limb dysmetria (26.9%), speech impairment (11.5%), blurred vision (7.7%), epileptic seizures (7.7%) and drowsiness (3.8%). The most common location for CVST was the transverse sinus (61.5%) followed by the superior sagittal sinus (30.8%). Anaemia, low albumin and elevated d-dimer were independent predictors of CVST in patients with IBD. Anticoagulation therapy was effective. The prognosis of IBD patients with CVST was worse than that of IBD patients without CVST. Early identification of the risk and clinical features of CVST in IBD patients is important. Prompt antithrombotic therapy is a safe and effective treatment.
first_indexed 2024-12-17T19:27:07Z
format Article
id doaj.art-a1a9a026ba5d4ca6864f35ed84ebf8df
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-17T19:27:07Z
publishDate 2021-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-a1a9a026ba5d4ca6864f35ed84ebf8df2022-12-21T21:35:22ZengNature PortfolioScientific Reports2045-23222021-08-011111510.1038/s41598-021-96541-yCerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective studyWang Shujun0Zhang Huijie1Bai Xia2Wang Hongjian3Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityAbstract Cerebral venous sinus thrombosis (CVST) is a rare and devastating complication of inflammatory bowel disease (IBD). Early diagnosis and prompt treatment could improve prognosis. The aim of our study was to investigate the clinical data and predictive factors of inflammatory bowel disease in patients with a diagnosis of CVST. All IBD patient data were collected from July 2013 and September 2020. Clinical data, predictive factors and prognosis were compared between IBD patients with CVST and the IBD control group. The incidence of CVST in our study was 0.48%. The mean age of IBD patients with CVST was 34.9 years. The average duration of IBD was 4 years when cerebrovascular events occurred. The clinical presentation of CVST included headache (73.1%), vomiting (30.8%), limb dysmetria (26.9%), speech impairment (11.5%), blurred vision (7.7%), epileptic seizures (7.7%) and drowsiness (3.8%). The most common location for CVST was the transverse sinus (61.5%) followed by the superior sagittal sinus (30.8%). Anaemia, low albumin and elevated d-dimer were independent predictors of CVST in patients with IBD. Anticoagulation therapy was effective. The prognosis of IBD patients with CVST was worse than that of IBD patients without CVST. Early identification of the risk and clinical features of CVST in IBD patients is important. Prompt antithrombotic therapy is a safe and effective treatment.https://doi.org/10.1038/s41598-021-96541-y
spellingShingle Wang Shujun
Zhang Huijie
Bai Xia
Wang Hongjian
Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study
Scientific Reports
title Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study
title_full Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study
title_fullStr Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study
title_full_unstemmed Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study
title_short Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study
title_sort cerebral venous sinus thrombosis in patients with inflammatory bowel disease a retrospective study
url https://doi.org/10.1038/s41598-021-96541-y
work_keys_str_mv AT wangshujun cerebralvenoussinusthrombosisinpatientswithinflammatoryboweldiseasearetrospectivestudy
AT zhanghuijie cerebralvenoussinusthrombosisinpatientswithinflammatoryboweldiseasearetrospectivestudy
AT baixia cerebralvenoussinusthrombosisinpatientswithinflammatoryboweldiseasearetrospectivestudy
AT wanghongjian cerebralvenoussinusthrombosisinpatientswithinflammatoryboweldiseasearetrospectivestudy